In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower teams to reach peak sales faster and with confidence.
Jennifer Green, senior global technical business development manager at Lubrizol explores importance of device design, as diabetes management is rapidly advancing, and the choice of materials is what helps distinguish good design.
Avantor, a provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has announced the launch of its pre-engineered PUPSIT (pre-use, post-sterilisation integrity testing) assemblies.
Lonza has signed an agreement to acquire Redberry SAS (Redberry), an innovative company specialising in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology.
ACG, has announced that its Personalised Medicine Concept (PMC) has been awarded the Red Dot Award for high design quality in the Medical Devices and Technology category.
Abzena, an end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotech company focused on the discovery and development of fully human antibodies, announced the formation of a strategic partnership.
With so much investor interest surrounding the potential of allogeneic CAR T cell therapies, the stakes are high for innovators to ensure that their inventions are robustly protected from the start.
PacBio has announced the publication of a new preprint from the HiFi Solves EMEA Consortium, “HiFi sequencing accurately identifies clinically relevant variants in paralogous genes.”
